Click on a filter below to refine your search. Remove a filter to broaden your search.
The cost increased from $10,394 at end of March 2020 to $13,072 at end of March 2022, and it was higher with specific comorbidities.
In contrast, post-COVID-19 myocarditis shows outcomes similar to conventional myocarditis.
No meaningful differences in mean laboratory values were seen between those with a PASC index of 12 or higher versus 0.
Female sex and preexisting cardiovascular disease were tied to longer recovery times.
The findings based on symptoms at 10 weeks following 15-day course in vaccinated cohort.
The deficits appear to be the greatest for individuals with the original untyped and alpha variant infections.
Small delayed benefit seen for loneliness, but larger improvements seen in perceived stress
44.9% of veterans with COVID-19 infection, and 35.3% without, reported that they could do less than before the pandemic.
Exit rates for healthcare workers increased at onset of pandemic and remained higher than baseline through 2021.
On day 5, the decrease in viral load from baseline was greater in the simnotrelvir group versus the placebo group.